{"id":567505,"date":"2021-10-05T21:30:02","date_gmt":"2021-10-05T21:30:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=567505"},"modified":"2021-10-05T21:30:02","modified_gmt":"2021-10-05T21:30:02","slug":"healthcare-analytical-testing-services-market-worth-98-billion-by-2026-key-players-are-eurofins-scientific-sgs-sa-charles-river-laboratories","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/healthcare-analytical-testing-services-market-worth-98-billion-by-2026-key-players-are-eurofins-scientific-sgs-sa-charles-river-laboratories_567505.html","title":{"rendered":"Healthcare Analytical Testing Services Market worth $9.8 billion by 2026 – Key Players are Eurofins Scientific, SGS S.A., Charles River Laboratories"},"content":{"rendered":"
\n
\"Healthcare<\/a><\/div>\n
\n
Key players in the Healthcare analytical testing services market include Eurofins Scientific (Luxembourg), Laboratory Corporation of America Holdings (US), SGS S.A. (Switzerland), Charles River Laboratories (US), WuXi AppTec Co. Ltd. (China), PPD, Inc. (US), Element Materials Technology (UK), Thermo Fisher Scientific (US), Pace Analytical Services, LLC. (US), Intertek Group LLC. (UK), Merck KGaA (Germany), Danaher Corporation (US)<\/div>\n<\/div>\n<\/div>\n
Healthcare Analytical Testing Services Market Research Report Gives in Detailed Analysis of Industry Segments, Opportunities, Growth and Size That Will Help Your Business Grow.<\/div>\n

According to the new market research report “<\/strong>Healthcare Analytical Testing Services Market<\/a> by Type (Method Development & Validation, Cell-based Assays, Stability Testing, Heavy Metal Testing, Thermal Analysis, Cleaning Validation), End User (Pharmaceutical Companies, CROs) – Global Forecast to 2026″,<\/strong> published by MarketsandMarkets™, the global market is projected to reach USD 9.8  billion by 2026 from USD 5.6 billion in 2021, at a CAGR of 11.9%.<\/p>\n

Browse in-depth TOC on <\/em>“Healthcare Analytical Testing Services Market”<\/strong><\/p>\n

314 – Tables<\/strong>
52 – Figures<\/strong>
357 – Pages<\/strong><\/strong><\/p>\n

Download PDF Brochure: <\/strong>https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=108923833<\/a><\/p>\n

The Growth in the market is driven by analytical testing of biologics and biosimilars, increasing outsourcing of analytical testing by pharmaceutical companies, and rising number of clinical trials.<\/p>\n

In this report the global healthcare analytical testing services market is segmented by type, end user, and region.<\/p>\n

Based on type, the market is segmented into bioanalytical testing, physical characterization, method development & validation, stability testing, batch-release testing, raw material testing, microbial testing, and environmental monitoring services.<\/p>\n

The bioanalytical testing segment holds the highest market share, by type, in the healthcare analytical testing services market, in the forecast period.<\/strong><\/p>\n

In 2020, the bioanalytical testing segment accounted for the largest share of the market. The large share of this segment can be attributed to large share of this segment is mainly attributed to the increasing number of drugs in the biopharmaceutical pipeline and the growing biopharmaceutical industry.<\/p>\n

The batch-release testing segment is expected to grow at the highest CAGR, by type, in the forecast period.<\/strong><\/p>\n

The batch-release testing segment is expected to grow at the highest CAGR in the forecast period. The highest growth of this segment can be attributed to necessity of these services to ensure the quality of pharmaceuticals and biopharmaceuticals before release for sale, supply, or export.<\/p>\n

Request Sample Pages: <\/strong>https:\/\/www.marketsandmarkets.com\/requestsampleNew.asp?id=108923833<\/a><\/p>\n

North America holds the highest market share, by region, in the forecast period<\/strong><\/p>\n

The healthcare analytical testing services market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. North America is expected to hold the highest market share, by region, in the forecast period. The high share of this market is due to the presence of a well-established base of pharmaceutical and biopharmaceutical companies, high investments in the biosimilars & biologics segment, and increasing R&D expenditure.<\/p>\n

Prominent players in the healthcare analytical testing services market include Eurofins Scientific (Luxembourg), Laboratory Corporation of America Holdings (US), SGS S.A. (Switzerland), Charles River Laboratories (US), WuXi AppTec Co. Ltd. (China), PPD, Inc. (US), Element Materials Technology (UK), Thermo Fisher Scientific (US), Pace Analytical Services, LLC. (US), Intertek Group LLC. (UK), Merck KGaA (Germany), Danaher Corporation (US), Source BioScience (UK), Almac Group (UK), ICON plc (Ireland), Frontage Laboratories, Inc. (US), STERIS plc (US), Sartorius AG (Germany), ALS Life Science (US), Syneos Health (US), Medpace Holdings, Inc. (US), Cinven (LGC Limited) (UK), Anacura (Belgium), Impact Analytical (US), & CD BioSciences (US).<\/p>\n

Media Contact<\/span>
Company Name:<\/strong> MarketsandMarkets<\/a>
Contact Person:<\/strong> Mr. Aashish Mehra
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> 18886006441
Address:<\/strong>630 Dundee Road Suite 430
City:<\/strong> Northbrook
State:<\/strong> IL 60062
Country:<\/strong> United States
Website:<\/strong> https:\/\/www.marketsandmarkets.com\/Market-Reports\/healthcare-analytical-testing-services-market-108923833.html<\/a><\/p>\n

<\/object>\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

Key players in the Healthcare analytical testing services market include Eurofins Scientific (Luxembourg), Laboratory Corporation of America Holdings (US), SGS S.A. (Switzerland), Charles River Laboratories (US), WuXi AppTec Co. Ltd. (China), PPD, Inc. (US), Element Materials Technology (UK), Thermo Fisher … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,435,406,403,404],"tags":[],"class_list":["post-567505","post","type-post","status-publish","format-standard","hentry","category-Business","category-Europe","category-Pharmaceuticals-Biotech","category-UK","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/567505","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=567505"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/567505\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=567505"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=567505"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=567505"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}